Causaly Brings AI-Powered Scientific Research to Microsoft Copilot
Causaly has expanded its partnership with Microsoft (NASDAQ: MSFT) by integrating agentic scientific research capabilities into Microsoft Copilot for enterprise life sciences teams. The integration allows Causaly to act as a specialized enterprise agent, orchestrating end-to-end scientific research that surfaces prior science and reasons over biological mechanisms.
Users can invoke Causaly from the agent menu or by @mentioning Causaly in a Copilot conversation, enabling complex biomedical questions to be answered within a familiar interface. Every answer produced by Causaly carries traceable references back to peer-reviewed literature, biomedical databases, and its proprietary knowledge graphs, Bio Graph and Pipeline Graph.
Yiannis Kiachopoulos, co-founder and CEO of Causaly, said, 'This puts governed, provenance-first scientific reasoning inside the same interface used across research, development, medical, and commercial functions in biopharma.'